View in EDS

IL-33 induces NF-κB activation in ILC2 that can be suppressed by in vivo and ex vivo 17β-estradiol.

Saved in:
Bibliographic Details
Title: IL-33 induces NF-κB activation in ILC2 that can be suppressed by in vivo and ex vivo 17β-estradiol.
Authors: Trivedi S; Division of Infectious Disease, Department of Internal Medicine, University of Utah, Salt Lake City, UT, United States.; George E Wahlen Department of Veterans Affairs Medical Center, VA Salt Lake City Health Care System, Salt Lake City, UT, United States., Labuz D; Division of Infectious Disease, Department of Internal Medicine, University of Utah, Salt Lake City, UT, United States., Deering-Rice CE; Department of Pharmacology and Toxicology, University of Utah College of Pharmacy, Salt Lake City, UT, United States., Kim CU; Division of Pulmonary Medicine, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, United States., Christensen H; Division of Pulmonary Medicine, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, United States., Aamodt S; Division of Pulmonary Medicine, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, United States., Huecksteadt T; George E Wahlen Department of Veterans Affairs Medical Center, VA Salt Lake City Health Care System, Salt Lake City, UT, United States., Sanders K; George E Wahlen Department of Veterans Affairs Medical Center, VA Salt Lake City Health Care System, Salt Lake City, UT, United States.; Division of Pulmonary Medicine, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, United States., Warren KJ; George E Wahlen Department of Veterans Affairs Medical Center, VA Salt Lake City Health Care System, Salt Lake City, UT, United States.; Division of Pulmonary Medicine, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, United States.
Source: Frontiers in allergy [Front Allergy] 2022 Nov 25; Vol. 3, pp. 1062412. Date of Electronic Publication: 2022 Nov 25 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 9918227355906676 Publication Model: eCollection Cited Medium: Internet ISSN: 2673-6101 (Electronic) Linking ISSN: 26736101 NLM ISO Abbreviation: Front Allergy Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36506643
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: IL-33 induces NF-κB activation in ILC2 that can be suppressed by in vivo and ex vivo 17β-estradiol.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Trivedi+S%22">Trivedi S</searchLink>; Division of Infectious Disease, Department of Internal Medicine, University of Utah, Salt Lake City, UT, United States.; George E Wahlen Department of Veterans Affairs Medical Center, VA Salt Lake City Health Care System, Salt Lake City, UT, United States.<br /><searchLink fieldCode="AU" term="%22Labuz+D%22">Labuz D</searchLink>; Division of Infectious Disease, Department of Internal Medicine, University of Utah, Salt Lake City, UT, United States.<br /><searchLink fieldCode="AU" term="%22Deering-Rice+CE%22">Deering-Rice CE</searchLink>; Department of Pharmacology and Toxicology, University of Utah College of Pharmacy, Salt Lake City, UT, United States.<br /><searchLink fieldCode="AU" term="%22Kim+CU%22">Kim CU</searchLink>; Division of Pulmonary Medicine, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, United States.<br /><searchLink fieldCode="AU" term="%22Christensen+H%22">Christensen H</searchLink>; Division of Pulmonary Medicine, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, United States.<br /><searchLink fieldCode="AU" term="%22Aamodt+S%22">Aamodt S</searchLink>; Division of Pulmonary Medicine, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, United States.<br /><searchLink fieldCode="AU" term="%22Huecksteadt+T%22">Huecksteadt T</searchLink>; George E Wahlen Department of Veterans Affairs Medical Center, VA Salt Lake City Health Care System, Salt Lake City, UT, United States.<br /><searchLink fieldCode="AU" term="%22Sanders+K%22">Sanders K</searchLink>; George E Wahlen Department of Veterans Affairs Medical Center, VA Salt Lake City Health Care System, Salt Lake City, UT, United States.; Division of Pulmonary Medicine, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, United States.<br /><searchLink fieldCode="AU" term="%22Warren+KJ%22">Warren KJ</searchLink>; George E Wahlen Department of Veterans Affairs Medical Center, VA Salt Lake City Health Care System, Salt Lake City, UT, United States.; Division of Pulmonary Medicine, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918227355906676%22">Frontiers in allergy</searchLink> [Front Allergy] 2022 Nov 25; Vol. 3, pp. 1062412. <i>Date of Electronic Publication: </i>2022 Nov 25 (<i>Print Publication: </i>2022).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Media+S%2EA%22">Frontiers Media S.A </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>9918227355906676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2673-6101 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226736101%22">26736101 </searchLink><i>NLM ISO Abbreviation: </i>Front Allergy <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36506643
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/falgy.2022.1062412
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1062412
    Titles:
      – TitleFull: IL-33 induces NF-κB activation in ILC2 that can be suppressed by in vivo and ex vivo 17β-estradiol.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Trivedi S
      – PersonEntity:
          Name:
            NameFull: Labuz D
      – PersonEntity:
          Name:
            NameFull: Deering-Rice CE
      – PersonEntity:
          Name:
            NameFull: Kim CU
      – PersonEntity:
          Name:
            NameFull: Christensen H
      – PersonEntity:
          Name:
            NameFull: Aamodt S
      – PersonEntity:
          Name:
            NameFull: Huecksteadt T
      – PersonEntity:
          Name:
            NameFull: Sanders K
      – PersonEntity:
          Name:
            NameFull: Warren KJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 11
              Text: 2022 Nov 25
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2673-6101
          Numbering:
            – Type: volume
              Value: 3
          Titles:
            – TitleFull: Frontiers in allergy
              Type: main
ResultId 1